Trade RCUS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Arcus Biosciences, Inc. (RCUS) is trading at US$29.66, down 1.56% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$3.86B. Over the past 52 weeks, RCUS has traded between US$11.04 and US$31.74. On Syfe you can trade RCUS with $0 commission and add it to your watchlist.
| Previous close | US$30.13 |
|---|---|
| Market cap | US$3.86B |
| 52-week range | US$11.04 – US$31.74 |
| Volume | 736.98K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Year: 2018
Wedbush Adjusts Price Target on Arcus Biosciences to $43 From $41, Maintains Outperform Rating
Aug 6, 1:01 PM · MT Newswires
-- Earnings Flash (RCUS) Arcus Biosciences, Inc. Reports Q2 Revenue $41.0M
Aug 5, 8:42 PM · MT Newswires
--BofA Securities Adjusts Arcus Biosciences Price Target to $29 From $25
Aug 3, 11:43 AM · MT Newswires
Arcus Biosciences, Inc. (RCUS) stock is trading at US$29.66, -1.56% from the previous close of US$30.13.
The market cap for Arcus Biosciences, Inc. (RCUS) stock is approximately US$3.86B.
The 52-week high for Arcus Biosciences, Inc. (RCUS) stock is US$31.74.
The 52-week low for Arcus Biosciences, Inc. (RCUS) stock is US$11.04.
Arcus Biosciences, Inc. (RCUS) does not currently pay a dividend.
Stay on top of RCUS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
